Published in Cancer Commun on January 01, 1990
Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A (1996) 2.31
Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res (1996) 1.47
Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res (1992) 1.11
Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance. Cytotechnology (1998) 0.75
Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 5.17
Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (1988) 4.49
Sleep-disordered breathing in community-dwelling elderly. Sleep (1991) 3.46
Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci U S A (1989) 3.27
Marital counselling in General Practice. Proc R Soc Med (1977) 3.02
Oligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Res (1988) 2.96
Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut (1996) 2.63
Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc Natl Acad Sci U S A (1989) 2.62
Cecal volvulus. Dis Colon Rectum (1990) 2.06
Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res (2001) 2.06
Diagnostic reliability of histological and cytological fine needle biopsies from focal liver lesions. Histopathology (1989) 2.00
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides. Nucleic Acids Res (1989) 1.98
Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res (1999) 1.93
Management of breast fibroadenomas. J Gen Intern Med (1998) 1.90
Timing light and tone signals in pigeons. J Exp Psychol Anim Behav Process (1989) 1.90
Factor VII related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch A Pathol Anat Histol (1981) 1.78
Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. Biochemistry (1989) 1.70
Prosthetic iris implantation for congenital, traumatic, or functional iris deficiencies. J Cataract Refract Surg (2001) 1.67
Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. Cancer Res (1990) 1.59
An alternating conformation characterizes the phosphodiester backbone of poly(dA-dT) in solution. J Biol Chem (1979) 1.56
A second locus for Rieger syndrome maps to chromosome 13q14. Am J Hum Genet (1996) 1.55
On the rapid deprotection of synthetic oligonucleotides and analogs. Nucleic Acids Res (1994) 1.54
The mechanism of action of ribonuclease. Proc Natl Acad Sci U S A (1969) 1.51
Periodic limb movements in sleep in community-dwelling elderly. Sleep (1991) 1.47
Role of cholecystostomy in the management of critically ill patients suffering from acute cholecystitis. Br J Surg (1989) 1.47
DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res (2001) 1.46
Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci (2004) 1.44
Internal pH and state of ATP in adrenergic chromaffin granules determined by 31P nuclear magnetic resonance spectroscopy. J Biol Chem (1979) 1.43
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene (2007) 1.40
Preventing disruption of special needs adoptions. Child Welfare (1990) 1.39
Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12. Biochemistry (1977) 1.38
Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy. Proc Natl Acad Sci U S A (1991) 1.37
Phospholipid metabolites as indicators of cancer cell function. NMR Biomed (1993) 1.36
Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. J Natl Cancer Inst (1992) 1.36
Characterization of alternating deoxyribonucleic acid conformations in solution by phosphorus-31 nuclear magnetic resonance spectroscopy. Biochemistry (1981) 1.33
Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. J Biol Chem (1987) 1.32
Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res (1988) 1.32
Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood (1995) 1.30
92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer (1996) 1.30
Electrospray ionization mass spectrometry analysis of changes in phospholipids in RBL-2H3 mastocytoma cells during degranulation. Proc Natl Acad Sci U S A (2001) 1.29
Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. Cancer Res (1989) 1.27
Carbon-13 nuclear magnetic resonance titration shifts in amino acids. J Am Chem Soc (1974) 1.26
Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV). Gene (1988) 1.26
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. Br J Ophthalmol (2008) 1.24
Nuclear magnetic resonance and neutron diffraction studies of the complex of ribonuclease A with uridine vanadate, a transition-state analogue. Biochemistry (1985) 1.23
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology (2000) 1.22
Nuclear magnetic resonance studies of the structure and binding sites of enzymes. I. Histidine residues. Proc Natl Acad Sci U S A (1967) 1.21
E2F-1-induced p53-independent apoptosis in transgenic mice. Oncogene (1998) 1.20
Conformational perturbation due to an extra adenosine in a self-complementary oligodeoxynucleotide duplex. Biopolymers (1987) 1.20
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma. Histopathology (2008) 1.18
Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob Agents Chemother (1990) 1.16
Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cells. J Biol Chem (1998) 1.16
Phosphorothioate and normal oligodeoxyribonucleotides with 5'-linked acridine: characterization and preliminary kinetics of cellular uptake. Gene (1988) 1.15
Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res Dev (1993) 1.14
Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase. J Biol Chem (1989) 1.13
Conformational transitions of synthetic DNA sequences with inserted bases, related to the dodecamer d(CGCGAATTCGCG). Nucleic Acids Res (1987) 1.13
Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. J Biol Chem (1990) 1.11
Endometriosis in abdominal scars: a diagnostic pitfall. Am Surg (1996) 1.10
Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application. Nucleic Acids Res (1993) 1.10
B to Z transition of double-stranded poly[deoxyguanylyl(3'-5')-5-methyldeoxycytidine] in solution by phosphorus-31 and carbon-13 nuclear magnetic resonance spectroscopy. Biochemistry (1983) 1.09
Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab Invest (1996) 1.09
Antibody tests in streptococcal pharyngitis. Streptozyme versus conventional methods. Clin Pediatr (Phila) (1973) 1.08
A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines. J Biol Chem (2000) 1.06
Oligodeoxynucleotides as antisense inhibitors of gene expression. Prog Nucleic Acid Res Mol Biol (1992) 1.06
Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application. Anticancer Drug Des (1993) 1.05
Spin-lattice relaxation times of imidazole protons and their relevance to NMR studies of proteins. Nature (1974) 1.04
Mathematical models for interacting groups in nuclear magnetic resonance titration curves. Biochemistry (1972) 1.03
Treatment of anthracycline extravasation with dexrazoxane. Clin Cancer Res (2000) 1.03
Product quality of parenteral vancomycin products in the United States. Antimicrob Agents Chemother (2012) 1.03
Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer. Lab Invest (2001) 1.03
Double-stranded cyclic oligonucleotides with non-nucleotide bridges. Bioconjug Chem (1995) 1.03
Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. Eur J Haematol (1992) 1.02
Aspartame as a dietary trigger of headache. Headache (1989) 1.02
Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res (1995) 1.02
(Aminomethyl)phosphonate derivatives of oligonucleotides. Bioconjug Chem (1994) 1.01
Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan. Br J Cancer (1995) 1.01
Nonchromaffin paraganglioma of the retroperitoneum. J Urol (1985) 1.01
The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity. Cancer Res (1991) 1.01
Mechanism of oligonucleotide loop formation in solution. Biochemistry (1986) 1.01
Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines. J Natl Cancer Inst (1987) 1.00
The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun (1990) 1.00
Carbon-13 nuclear-magnetic-resonance studies on selected amino acids, peptides, and proteins. Eur J Biochem (1973) 0.99
Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci (2000) 0.99
Poly(d2NH2A-dT): two-dimensional NMR shows a B to A conversion in high salt. Biochemistry (1985) 0.97
Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. Cancer Res (1986) 0.97
Gas-liquid chromatography-mass spectrometry of carbon-13 enriched amino acids as trimethylsilyl derivatives. Biochim Biophys Acta (1970) 0.96
Nuclear magnetic resonance titration curves of histidine ring protons. I. Influence of neighboring charged groups. J Biol Chem (1971) 0.96
Interaction of oligonucleotides with cationic lipids: the relationship between electrostatics, hydration and state of aggregation. Biochim Biophys Acta (2000) 0.95
Carbon-13 nuclear magnetic resonance studies of proteins. Annu Rev Biophys Bioeng (1977) 0.95
Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells. J Biol Chem (1990) 0.94
Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis. J Am Coll Surg (1995) 0.94
Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab Invest (1997) 0.94
Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies. Cancer Res (1990) 0.94